Highlights: v GS2523 1.24 g/t A over 277.1 m incl 3.63g/t Au over 45.4m v GS2509 1.16 g/t…
Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
The ESC M&PD meeting brings together the world’s experts working to improve the treatment of myocarditis and pericarditis. Presentation…